PITUITARY HYPERPLASIA

This adverse event was reported 10 times

PITUITARY HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MARAVIROC 2 0.0009
1 ZIPRASIDONE 3 0.0008
2 ETRAVIRINE 2 0.0005
3 RALTEGRAVIR 2 0.0004
4 PRAZOSIN 2 0.0003
5 ASENAPINE MALEATE 2 0.0002
6 ZIPRASIDONE MESYLATE 3 0.0002
7 EPOPROSTENOL 2 0.0002
8 OXCARBAZEPINE 2 0.0001
9 LIOTHYRONINE SODIUM 1 0.0001
See all drugs enriched for association with PITUITARY HYPERPLASIA